| 1 |
Comparison of Safety Profiles of the New and Old Formulations of Levothyroxine in a First Global Introduction in France |
|
| | Hendrik Lehnert,Claire Castello-Bridoux,Bushan Channaiah,Karine Martiniere,Steven Hildemann,Jean-Louis Wémeau | | | Experimental and Clinical Endocrinology & Diabetes. 2021; | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
The Effects of 8 Weeks of Levothyroxine Replacement Treatment on Metabolic and Anthropometric Indices of Insulin Resistance in Hypothyroid Patients |
|
| | Roya Pasandideh,Seyed M. Hosseini,Gholamreza Veghari,Sharebeh Hezarkhani | | | Endocrine, Metabolic & Immune Disorders - Drug Targets. 2020; 20(5): 745 | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
Health-Related Quality of Life in Levothyroxine-Treated Hypothyroid Women and Women without Hypothyroidism: A Case–Control Study |
|
| | Benjamín Romero-Gómez,Paula Guerrero-Alonso,Juan Manuel Carmona-Torres,Diana P. Pozuelo-Carrascosa,José Alberto Laredo-Aguilera,Ana Isabel Cobo-Cuenca | | | Journal of Clinical Medicine. 2020; 9(12): 3864 | | | [Pubmed] [Google Scholar] [DOI] | | | 4 |
Correlation between TSH levels and quality of life among subjects with well-controlled primary hypothyroidism |
|
| | Marta Morón-Díaz,Pedro Saavedra,María P. Alberiche-Ruano,Carlos A. Rodríguez-Pérez,Yaiza López-Plasencia,Dunia Marrero-Arencibia,Ana M. González-Lleó,Mauro Boronat | | | Endocrine. 2020; | | | [Pubmed] [Google Scholar] [DOI] | |
|
